Aibin Liang

18PUBLICATIONS
60CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Genomics and transcriptomicsInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 14, 2026
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up.

|Apr 21, 2026
TRIM37-Mediated Ubiquitination and Degradation of KMT2D Activates JAK2-STAT3 Signaling to Promote Diffuse Large B-Cell Lymphoma Progression.

|Mar 31, 2026
Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Mingqi Hou, Wenjun Zhang, Ziping Qi

|Dec 11, 2025
Benchmarking algorithms for generalizable single-cell perturbation response prediction.

Zhiting Wei, Yiheng Wang, Yicheng Gao

|Aug 14, 2025
A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronaviruses.

Lei Yan, Fulian Wang, Michelle Hill

|Jul 03, 2025
Author Correction: Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.

Wen Lei, Hui Liu, Wenhai Deng

Pageof 3

Frequent Collaborators

3 joint publications

Guangming Wang

3 joint publications

Wenbin Qian

2 joint publications

Wenhai Deng

2 joint publications

Yi Eve Sun